| | | 69255 | | 21.08.2024 | | Novartis Pharma Schweiz AG | | | | | | | 20.08.2029 | | | | | | | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Entresto 6 mg/6 mg | filmüberzogenes Granulat | filmüberzogenes Granulat (Sacubitrilum 6.1 mg, Valsartan 6.4 mg) | C09DX04 | CI | | 02 | Entresto 15 mg/16 mg | filmüberzogenes Granulat | filmüberzogenes Granulat (Sacubitrilum 15.18 mg, Valsartan 16.07 mg) | C09DX04 | |
|
|
